TY - JOUR
T1 - Determinants of arterial pressure after chronic spinal transection in rats
AU - Osborn, J. W.
AU - Taylor, R. F.
AU - Schramm, L. P.
PY - 1989
Y1 - 1989
N2 - The present study was conducted to determine whether sympathetic vasoconstrictor activity is a determinant of mean arterial pressure (MAP) hours and days after cervical spinal transection (CST) in unanesthetized rats. MAP on the 2 days before CST was 107.2 ± 3.6 and 103.3 mmHg, respectively, and fell to 77.7 ± 1.1 mmHg on day 1 after CST. MAP returned to control levels over the course of the study and, by day 9 after CST, was not statistically different from control (98.6 ± 3.4 mmHg). Neither autonomic ganglionic blockade nor α-adrenergic blockade affected MAP the 1st day after CST. Similarly, α-adrenergic blockade was without effect on days 3, 5, and 7 after CST. Administration of a vasopressin V1-antagonist had no effect on MAP on day 1 or day 8 after CST. However, blockade of angiotensin-converting enzyme with captopril decreased arterial pressure both on day 1 (-22.1 ± 2.6 mmHg) and day 8 (-23.3 ± 2.9 mmHg) after CST. We conclude that neither sympathetic nor vasopressin vasoconstrictor activity affected MAP within the 1st wk after CST. Although the vasoconstrictor actions of angiotensin II were important, these effects were not responsible for the normalization of MAP observed after CST.
AB - The present study was conducted to determine whether sympathetic vasoconstrictor activity is a determinant of mean arterial pressure (MAP) hours and days after cervical spinal transection (CST) in unanesthetized rats. MAP on the 2 days before CST was 107.2 ± 3.6 and 103.3 mmHg, respectively, and fell to 77.7 ± 1.1 mmHg on day 1 after CST. MAP returned to control levels over the course of the study and, by day 9 after CST, was not statistically different from control (98.6 ± 3.4 mmHg). Neither autonomic ganglionic blockade nor α-adrenergic blockade affected MAP the 1st day after CST. Similarly, α-adrenergic blockade was without effect on days 3, 5, and 7 after CST. Administration of a vasopressin V1-antagonist had no effect on MAP on day 1 or day 8 after CST. However, blockade of angiotensin-converting enzyme with captopril decreased arterial pressure both on day 1 (-22.1 ± 2.6 mmHg) and day 8 (-23.3 ± 2.9 mmHg) after CST. We conclude that neither sympathetic nor vasopressin vasoconstrictor activity affected MAP within the 1st wk after CST. Although the vasoconstrictor actions of angiotensin II were important, these effects were not responsible for the normalization of MAP observed after CST.
UR - http://www.scopus.com/inward/record.url?scp=0024565187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024565187&partnerID=8YFLogxK
M3 - Article
C2 - 2923255
AN - SCOPUS:0024565187
SN - 0002-9513
VL - 256
SP - 25/3
JO - American Journal of Physiology - Regulatory Integrative and Comparative Physiology
JF - American Journal of Physiology - Regulatory Integrative and Comparative Physiology
IS - 3
ER -